FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3111927518> ?p ?o ?g. }

• W3111927518 endingPage "1516" @default.
• W3111927518 startingPage "1507" @default.
• W3111927518 abstract "Background Multiple international organizations have called for exercise to become standard practice in the setting of oncology care. The feasibility of integrating exercise within systemic chemotherapy has not been investigated. Methods Patients slated to receive infusion therapy between April 2017 and October 2018 were screened for possible inclusion. The study goal was to establish the acceptability and feasibility of embedding an exercise professional into the chemotherapy infusion suite as a method of making exercise a standard part of cancer care. The exercise prescriptions provided to patients were individualized according to results of brief baseline functional testing. Results In all, 544 patients were screened, and their respective treating oncologists deemed 83% of them to be medically eligible to participate. After further eligibility screening, 226 patients were approached. Nearly 71% of these patients (n = 160) accepted the invitation to participate in the Exercise in All Chemotherapy trial. Feasibility was established because 71%, 55%, 69%, and 63% of the aerobic, resistance, balance, and flexibility exercises prescribed to patients were completed. Qualitative data also supported the acceptability and feasibility of the intervention from the perspective of patients and clinicians. The per‐patient cost of the intervention was $190.68 to $382.40. Conclusions Embedding an exercise professional into the chemotherapy infusion suite is an acceptable and feasible approach to making exercise standard practice. Moreover, the cost of the intervention is lower than the cost of other common community programs. Future studies should test whether colocating an exercise professional with infusion therapy could reach more patients in comparison with not colocating. Lay Summary Few studies have tested the implementation of exercise for patients with cancer by embedding an exercise professional directly into the chemotherapy infusion suite. The Exercise in All Chemotherapy trial shows that this approach is both acceptable and feasible from the perspective of clinicians and patients." @default.
• W3111927518 created "2020-12-21" @default.
• W3111927518 creator A5000159790 @default.
• W3111927518 creator A5006518041 @default.
• W3111927518 creator A5018176156 @default.
• W3111927518 creator A5036666860 @default.
• W3111927518 creator A5043220508 @default.
• W3111927518 creator A5052750238 @default.
• W3111927518 creator A5052843019 @default.
• W3111927518 creator A5067029478 @default.
• W3111927518 creator A5076705560 @default.
• W3111927518 creator A5079776453 @default.
• W3111927518 creator A5090252951 @default.
• W3111927518 date "2020-12-17" @default.
• W3111927518 modified "2023-10-10" @default.
• W3111927518 title "The exercise in all chemotherapy trial" @default.
• W3111927518 cites W1979290264 @default.
• W3111927518 cites W1991881145 @default.
• W3111927518 cites W2010439133 @default.
• W3111927518 cites W2076668534 @default.
• W3111927518 cites W2098952286 @default.
• W3111927518 cites W2120888944 @default.
• W3111927518 cites W2593266874 @default.
• W3111927518 cites W2751740330 @default.
• W3111927518 cites W2765762403 @default.
• W3111927518 cites W2945461482 @default.
• W3111927518 cites W2953078460 @default.
• W3111927518 cites W2980368443 @default.
• W3111927518 cites W2981263606 @default.
• W3111927518 cites W3014043079 @default.
• W3111927518 doi "https://doi.org/10.1002/cncr.33390" @default.
• W3111927518 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33332587" @default.
• W3111927518 hasPublicationYear "2020" @default.
• W3111927518 type Work @default.
• W3111927518 sameAs 3111927518 @default.
• W3111927518 citedByCount "6" @default.
• W3111927518 countsByYear W31119275182021 @default.
• W3111927518 countsByYear W31119275182023 @default.
• W3111927518 crossrefType "journal-article" @default.
• W3111927518 hasAuthorship W3111927518A5000159790 @default.
• W3111927518 hasAuthorship W3111927518A5006518041 @default.
• W3111927518 hasAuthorship W3111927518A5018176156 @default.
• W3111927518 hasAuthorship W3111927518A5036666860 @default.
• W3111927518 hasAuthorship W3111927518A5043220508 @default.
• W3111927518 hasAuthorship W3111927518A5052750238 @default.
• W3111927518 hasAuthorship W3111927518A5052843019 @default.
• W3111927518 hasAuthorship W3111927518A5067029478 @default.
• W3111927518 hasAuthorship W3111927518A5076705560 @default.
• W3111927518 hasAuthorship W3111927518A5079776453 @default.
• W3111927518 hasAuthorship W3111927518A5090252951 @default.
• W3111927518 hasBestOaLocation W31119275181 @default.
• W3111927518 hasConcept C103038586 @default.
• W3111927518 hasConcept C126322002 @default.
• W3111927518 hasConcept C151730666 @default.
• W3111927518 hasConcept C159110408 @default.
• W3111927518 hasConcept C168563851 @default.
• W3111927518 hasConcept C177713679 @default.
• W3111927518 hasConcept C1862650 @default.
• W3111927518 hasConcept C2426938 @default.
• W3111927518 hasConcept C2776694085 @default.
• W3111927518 hasConcept C2777267654 @default.
• W3111927518 hasConcept C2779673892 @default.
• W3111927518 hasConcept C2780665704 @default.
• W3111927518 hasConcept C535046627 @default.
• W3111927518 hasConcept C71924100 @default.
• W3111927518 hasConcept C86803240 @default.
• W3111927518 hasConceptScore W3111927518C103038586 @default.
• W3111927518 hasConceptScore W3111927518C126322002 @default.
• W3111927518 hasConceptScore W3111927518C151730666 @default.
• W3111927518 hasConceptScore W3111927518C159110408 @default.
• W3111927518 hasConceptScore W3111927518C168563851 @default.
• W3111927518 hasConceptScore W3111927518C177713679 @default.
• W3111927518 hasConceptScore W3111927518C1862650 @default.
• W3111927518 hasConceptScore W3111927518C2426938 @default.
• W3111927518 hasConceptScore W3111927518C2776694085 @default.
• W3111927518 hasConceptScore W3111927518C2777267654 @default.
• W3111927518 hasConceptScore W3111927518C2779673892 @default.
• W3111927518 hasConceptScore W3111927518C2780665704 @default.
• W3111927518 hasConceptScore W3111927518C535046627 @default.
• W3111927518 hasConceptScore W3111927518C71924100 @default.
• W3111927518 hasConceptScore W3111927518C86803240 @default.
• W3111927518 hasFunder F4320337703 @default.
• W3111927518 hasIssue "9" @default.
• W3111927518 hasLocation W31119275181 @default.
• W3111927518 hasOpenAccess W3111927518 @default.
• W3111927518 hasPrimaryLocation W31119275181 @default.
• W3111927518 hasRelatedWork W2059990758 @default.
• W3111927518 hasRelatedWork W2317118711 @default.
• W3111927518 hasRelatedWork W2341334583 @default.
• W3111927518 hasRelatedWork W2358949696 @default.
• W3111927518 hasRelatedWork W2361820086 @default.
• W3111927518 hasRelatedWork W2366044852 @default.
• W3111927518 hasRelatedWork W2368224867 @default.
• W3111927518 hasRelatedWork W2385685139 @default.
• W3111927518 hasRelatedWork W2392434588 @default.
• W3111927518 hasRelatedWork W3029903131 @default.
• W3111927518 hasVolume "127" @default.
• W3111927518 isParatext "false" @default.

• next